What is Bioventus Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Bioventus Inc.'s reported free cash flow gives $31.68 per share. The share price was $11.18 on November 10, 2026, 65% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 10.0% | 10.0% | $18.12 | +62% |
| Base | 15.0% | 9.0% | $31.68 | +183% |
| Bull | 20.0% | 8.0% | $56.94 | +409% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $41.95 | $45.16 | $49.07 | $53.96 | $60.25 |
| 8.0% | $34.24 | $36.31 | $38.77 | $41.71 | $45.31 |
| 9.0% | $28.62 | $30.04 | $31.68 | $33.59 | $35.85 |
| 10.0% | $24.37 | $25.38 | $26.52 | $27.83 | $29.34 |
| 11.0% | $21.04 | $21.78 | $22.60 | $23.53 | $24.59 |
Where the presets come from
Base: years 1 to 5 grow at Bioventus Inc.'s revenue growth rate over the last 4 fiscal years (15.3% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions